Anavex Life Sciences Corp (AVXL)
3.89
+0.18
(+4.85%)
USD |
NASDAQ |
May 09, 16:00
3.94
+0.05
(+1.29%)
Pre-Market: 08:10
Anavex Life Sciences Total Assets (Quarterly): 148.07M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 148.07M |
| September 30, 2023 | 154.39M |
| June 30, 2023 | 157.81M |
| March 31, 2023 | 159.19M |
| December 31, 2022 | 148.37M |
| September 30, 2022 | 152.70M |
| June 30, 2022 | 160.22M |
| March 31, 2022 | 160.28M |
| December 31, 2021 | 156.90M |
| September 30, 2021 | 161.62M |
| June 30, 2021 | 166.42M |
| March 31, 2021 | 83.57M |
| December 31, 2020 | 54.33M |
| September 30, 2020 | 34.54M |
| June 30, 2020 | 31.63M |
| March 31, 2020 | 31.02M |
| December 31, 2019 | 31.42M |
| September 30, 2019 | 25.33M |
| June 30, 2019 | 21.97M |
| March 31, 2019 | 20.55M |
| December 31, 2018 | 22.10M |
| September 30, 2018 | 26.21M |
| June 30, 2018 | 26.79M |
| March 31, 2018 | 25.90M |
| December 31, 2017 | 28.34M |
| Date | Value |
|---|---|
| September 30, 2017 | 27.84M |
| June 30, 2017 | 24.91M |
| March 31, 2017 | 23.61M |
| December 31, 2016 | 21.37M |
| September 30, 2016 | 9.499M |
| June 30, 2016 | 9.844M |
| March 31, 2016 | 12.12M |
| December 31, 2015 | 14.02M |
| September 30, 2015 | 15.47M |
| June 30, 2015 | 7.979M |
| March 31, 2015 | 6.364M |
| December 31, 2014 | 7.050M |
| September 30, 2014 | 7.354M |
| June 30, 2014 | 9.314M |
| March 31, 2014 | 10.29M |
| December 31, 2013 | 0.1509M |
| September 30, 2013 | 0.3934M |
| June 30, 2013 | 0.0035M |
| March 31, 2013 | 0.0005M |
| December 31, 2012 | 0.0799M |
| September 30, 2012 | 0.0132M |
| June 30, 2012 | 0.0221M |
| March 31, 2012 | 0.1911M |
| December 31, 2011 | 0.0846M |
| September 30, 2011 | 0.203M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.97M
Minimum
Jun 2019
166.42M
Maximum
Jun 2021
107.36M
Average
148.37M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Ventyx Biosciences Inc | 277.69M |
| Checkpoint Therapeutics Inc | 5.378M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.50M |
| Shareholders Equity (Quarterly) | 135.58M |